DOSSIER · 13F Holders · Q1 2026
AKTX

AKARI THERAPEUTICS PLC

6 institutions still hold AKARI THERAPEUTICS PLC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 00972G405·6 13F holders·last filed Mar 31, 2026
Market cap
13F value held
$307K
visible holders
Holders
6
filers reporting
Concentration
65.23%
ARMISTICE CAPITAL, LLC #1
top holder share
AI Holders Summary · Q1 2026

6 institutions reported AKTX in Q1 2026. ARMISTICE CAPITAL, LLC leads at 65.2% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
ARMISTICE CAPITAL, LLC
CIK 0001601086
$200K39K0.00%Q1 2026
02
Cresset Asset Management, LLC
CIK 0001761013
$106K21K0.00%Q1 2026
03
IFP Advisors, Inc
CIK 0001641866
$9321810.00%Q1 2026
04
SBI Securities Co., Ltd.
CIK 0001851815
$2650.00%Q1 2026
05
Truvestments Capital LLC
CIK 0001750405
$510.00%Q1 2026
06
MORGAN STANLEY
CIK 0000895421
$510.00%Q1 2026
Insiders at AKARI THERAPEUTICS PLC
Gaslightwala AbizerFarag Kameel D.Prudo-Chlebosz RaymondPatel Sandip IPatel Samir RashmikantBazemore Robert BHuh Hoyoung